Teva and Eagle try to block Bendeka generic
01-07-2021
Fed Circuit limits venue options for generic patent suits
06-11-2020
FDA warns of ‘grave’ knock-on effects from Eagle decision
29-05-2020
FDA approves Hikma’s Vascepa generic
26-05-2020
Cochlear's $268m damages bill stands, says Fed Circuit
20-05-2020
Fed Circuit rejects Biogen’s plea in MS drug dispute
23-04-2020
Eli Lilly and Eagle Pharma settle antitrust and infringement claims
18-12-2019